SHANGHAI, April 10 (Reuters) - Amgen's lung cancer drug tarlatamab has won approval from China's National Medical Products Administration, its development and commercialisation partner BeOne Medicines ...

Treprostinil is a potent drug for various lung diseases because it opens blood vessels, reduces lung scarring, inhibits ...

Avalyn Pharma is eyeing an IPO as the biotech seeks more funds to take its inhaled versions of approved drugs for lung ...

AP01 has completed a phase 1b trial (ATLAS) in idiopathic pulmonary fibrosis (IPF) and has started an open-label extension in ...

Shanghai: Amgen's lung cancer drug tarlatamab has won approval from ​China's National Medical Products Administration, its ...

Why does fluid build in the chest? Here’s what to know after Gov. Kay Ivey’s procedure, including common causes, symptoms and ...

Tozorakimab met the primary goal in two late-stage clinical trials, reducing the rate at which patients’ symptoms worsened, ...

Just think, we may have never gotten the “Oh, oh, oh, Ozempic!” jingle stuck in our heads if it wasn’t for a creepy, ...

A yearlong investigation found K2-laced “paper hits” driving violence and deaths — while smuggling persists despite costly ...

In a preclinical study published today in Cancer Research, a journal of the American Association for Cancer Research, ...

The Health Insurance Fund (Tervisekassa) expanded its list of reimbursable medicines at the start of the month.

Detailed price information for Cspc Pharm Group Ltd Ord (CHJTF) from The Globe and Mail including charting and trades.